HIV and AIDS Trial, Recruiting (NCT06586151)

HIV and AIDS Trial, Recruiting NCT06586151 Sponsor: Center for Innovative Public Health Research Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06586151 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who were assigned male at birth and currently identify as a gender other than cisgender male (for example, transgender girl, non-binary, gender fluid, or unsure about their gender identity)
People aged 14 to 18 years old who have not yet graduated high school
People who speak English
People who are the only user of a cell phone that has an unlimited text messaging plan
People who have access to the internet to complete online surveys
People who plan to keep the same cell phone number for the next 6 months
People who are willing to provide informed assent (a formal agreement to take part in the study)
People who have not previously taken part in a #TranscendentHealth study activity, and who do not personally know anyone already in the study (this is to ensure a wide variety of participants)
People who are willing to enroll in the study over the phone with study staff

Who may not be able to join:

People who do not meet all of the criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8773026858

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06586151

Sponsor: Center for Innovative Public Health Research

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: 8773026858

More information: https://clinicaltrials.gov/study/NCT06586151

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who were assigned male at birth and currently identify as a gender other than cisgender male (for example, transgender girl, non-binary, gender fluid, or unsure about their gender identity)
People aged 14 to 18 years old who have not yet graduated high school
People who speak English
People who are the only user of a cell phone that has an unlimited text messaging plan
People who have access to the internet to complete online surveys
People who plan to keep the same cell phone number for the next 6 months
People who are willing to provide informed assent (a formal agreement to take part in the study)
People who have not previously taken part in a #TranscendentHealth study activity, and who do not personally know anyone already in the study (this is to ensure a wide variety of participants)
People who are willing to enroll in the study over the phone with study staff

Who may not be able to join:

People who do not meet all of the criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Center for Innovative Public Health Research

Registry

ClinicalTrials.gov

Start date

1 September 2024

Est. completion

30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number testing for HIV and/or sexual transmitted infections

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov